Profile
Marc A.
Cohen is the founder of several companies, including OPNET Technologies, Inc. (founded in 1986), Acetylon Pharmaceuticals, Inc. (founded in 2008), C4 Therapeutics, Inc. (founded in 2015), Cobro Ventures, Inc. (founded in 2012), Regenacy Pharmaceuticals LLC (founded in 2016), Mana Therapeutics, Inc. (founded in 2016), and NextRNA Therapeutics, Inc. (founded in 2021).
He held various titles at these companies, including Chairman, Chief Executive Officer, Secretary, Treasurer, and Executive Chairman.
Mr. Cohen is also the founder of AI Proteins, Inc. Mr. Cohen's former jobs include President & Chief Executive Officer of Opnet Analysis, Inc., Co-Chief Executive Officer of Bublup, Inc., Executive Chairman of OncoPep, Inc., Chairman of Frequency Therapeutics, Inc., Executive Chairman of Raqia Therapeutics, Inc., Chief Financial Officer of Trusted Information Systems, Inc., Chief Financial Officer & Treasurer of OTG Software, Inc., Trustee & Board Member of Dana-Farber Cancer Institute, Inc., and Chief Financial Officer, Secretary & Treasurer of Air Cargo, Inc. and PharmAthene, Inc. Mr. Cohen's education includes an undergraduate degree from Harvard University and a graduate degree from Stanford University.
Former positions of Marc A. Cohen
Companies | Position | End |
---|---|---|
AI Proteins, Inc.
AI Proteins, Inc. Pharmaceuticals: MajorHealth Technology AI Proteins, Inc. is a biotech company based in Andover, MA. AI Proteins is focused on re-imagining protein therapeutics by designing entirely new proteins using an AI-based approach and a high-throughput drug discovery platform. The company's platform enables the development of inexpensive, durable, and highly specific proteins optimized for specific therapeutic applications. These proteins have the potential for oral delivery and can dramatically accelerate the development of lead therapeutic candidates ready for IND-enabling studies. The company was founded by Marc A. Cohen and Christopher Bahl. Noah D. Beerman has been the CEO of the company since 2023. | Founder | 2022-05-31 |
C4 THERAPEUTICS, INC. | Chief Executive Officer | 2020-10-01 |
NextRNA Therapeutics, Inc.
NextRNA Therapeutics, Inc. BiotechnologyHealth Technology NextRNA Therapeutics, Inc. is a biotechnology company that specializes in drug development services. The company is based in Cambridge, MA. The company was founded in 2021 by Leon Wert-Lamas, Marc A. Cohen, Julia Novina, Carl Novina, Dominique Verhelle, Kenneth C. Anderson, Robert S. Langer. Dominique Verhelle has been the CEO since 2021. | Founder | 2022-05-31 |
Raqia Therapeutics, Inc. | Chairman | 2022-05-31 |
Regenacy Pharmaceuticals LLC
Regenacy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Regenacy Pharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It develops treatments for diabetic and peripheral neuropathies. The firm provides treatments through regeneration of normal protein function using oral, isoform selective histone deacetylase enzyme inhibitors. It provides treatment for diseases such as sickle cell disease, ß-thalassemia, leukemia, and cognitive dysfunction in neurological disorders. The company was founded by Marc A. Cohen in December 2016 and is headquartered in Waltham, MA. | Founder | 2022-05-31 |
Training of Marc A. Cohen
Harvard University | Undergraduate Degree |
Stanford University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
C4 THERAPEUTICS, INC. | Health Technology |
Private companies | 18 |
---|---|
OPNET Technologies, Inc.
OPNET Technologies, Inc. Packaged SoftwareTechnology Services OPNET Technologies, Inc. provided application and network performance management solutions. The company's engaged in software products address applications performance management, network planning, engineering and operations, and network research and development. OPNET's solutions deliver broad visibility and monitoring across infrastructure domains as well as deep data collection and analytics to enable powerful root cause diagnosis. The company markets software products and related services in North America primarily through a direct sales force and, to a lesser extent, through a sales program to extend its market reach called the Synergy Program. The company sells products to corporate enterprises, government and defense agencies, network service providers, and network equipment manufacturers. OPNET Technologies was founded by Marc A. Cohen and Alain J. Cohen in 1986 and was headquartered in Bethesda, MD. | Technology Services |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Health Services |
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | Health Technology |
Air Cargo, Inc.
Air Cargo, Inc. Air Freight/CouriersTransportation Air Cargo, Inc. provides logistics and other cargo services. The company is headquartered in Annapolis, MD | Transportation |
OTG Software, Inc.
OTG Software, Inc. Packaged SoftwareTechnology Services OTG Software, Inc. provides on-line storage management and data access solution | Technology Services |
Trusted Information Systems, Inc.
Trusted Information Systems, Inc. Packaged SoftwareTechnology Services Part of McAfee Corp., Trusted Information Systems, Inc. makes security solutions for computer networks. The company is based in Glenwood, MD. Trusted Information Systems was acquired by Networks Associates, Inc. on April 29, 1998 for $297.18 million. | Technology Services |
Acetylon Pharmaceuticals, Inc.
Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acetylon Pharmaceuticals, Inc. develops pharmaceutical technology. It develops novel small molecule drugs which targets epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The company was founded by Ralph Mazitschek, Kenneth C. Anderson, Marc A. Cohen, James E. Bradner, and Walter C. Ogier in October 2008 and is headquartered in Boston, MA. | Health Technology |
Opnet Analysis, Inc.
Opnet Analysis, Inc. Information Technology ServicesTechnology Services Opnet Analysis, Inc. provides custom computer programming services. It offers MIS, system administrators, information retrieval systems, data services, internet services, software maintenance and support, computer services, software or hardware engineering. The company is headquartered in Bethesda, MD. | Technology Services |
Booz Allen Hamilton, Inc.
Booz Allen Hamilton, Inc. Engineering & ConstructionIndustrial Services Booz Allen Hamilton, Inc. engages in the provision of management and technology consulting services. Its services include consulting, analytics, digital solutions, engineering, cyber security, and product. The company was founded by Edwin G. Booz in 1914 and is headquartered in McLean, VA. | Industrial Services |
Cobro Ventures, Inc.
Cobro Ventures, Inc. Investment ManagersFinance Cobro Ventures, Inc. ( Cobro Ventures ) is a venture capital firm founded in 2013 by Marc A. Cohen. The firm is headquartered in Arlington, Virginia. | Finance |
Frequency Therapeutics, Inc.
Frequency Therapeutics, Inc. BiotechnologyHealth Technology Frequency Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the business of developing therapeutics to activate a person's innate regenerative potential to restore function. The firm is also involved in creating and commercializing therapeutics to potentially transform the lives of individuals by repairing or reversing damage done to cells, tissue, and organs. The company was founded by Robert S. Langer, David L. Lucchino, Christopher R. Loosey, and Will J. McLean on November 13, 2014 and is headquartered in Lexington, MA. | Health Technology |
OncoPep, Inc.
OncoPep, Inc. Investment ManagersFinance OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA. | Finance |
Bublup, Inc.
Bublup, Inc. Internet Software/ServicesTechnology Services Bublup, Inc. engages in the development of a cloud platform for saving photos and documents. The company was founded on December 27, 2011 and is headquartered in Arlington, VA. | Technology Services |
Mana Therapeutics, Inc.
Mana Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mana Therapeutics, Inc. provides clinical cell immune therapies that can eliminate cancer cells. The company was founded by Catherine Bollard, Patrick Hanley, C. Russell Y. Cruz and Marc Cohen and is headquartered in Arlington, VA. | Commercial Services |
Regenacy Pharmaceuticals LLC
Regenacy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Regenacy Pharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It develops treatments for diabetic and peripheral neuropathies. The firm provides treatments through regeneration of normal protein function using oral, isoform selective histone deacetylase enzyme inhibitors. It provides treatment for diseases such as sickle cell disease, ß-thalassemia, leukemia, and cognitive dysfunction in neurological disorders. The company was founded by Marc A. Cohen in December 2016 and is headquartered in Waltham, MA. | Health Technology |
Raqia Therapeutics, Inc. | |
NextRNA Therapeutics, Inc.
NextRNA Therapeutics, Inc. BiotechnologyHealth Technology NextRNA Therapeutics, Inc. is a biotechnology company that specializes in drug development services. The company is based in Cambridge, MA. The company was founded in 2021 by Leon Wert-Lamas, Marc A. Cohen, Julia Novina, Carl Novina, Dominique Verhelle, Kenneth C. Anderson, Robert S. Langer. Dominique Verhelle has been the CEO since 2021. | Health Technology |
AI Proteins, Inc.
AI Proteins, Inc. Pharmaceuticals: MajorHealth Technology AI Proteins, Inc. is a biotech company based in Andover, MA. AI Proteins is focused on re-imagining protein therapeutics by designing entirely new proteins using an AI-based approach and a high-throughput drug discovery platform. The company's platform enables the development of inexpensive, durable, and highly specific proteins optimized for specific therapeutic applications. These proteins have the potential for oral delivery and can dramatically accelerate the development of lead therapeutic candidates ready for IND-enabling studies. The company was founded by Marc A. Cohen and Christopher Bahl. Noah D. Beerman has been the CEO of the company since 2023. | Health Technology |
- Stock Market
- Insiders
- Marc A. Cohen